RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia

Authors

Tim Kong, Washington University School of Medicine in St. Louis
Angelo B A Laranjeira, Washington University School of Medicine in St. Louis
Christopher T Letson, Washington University School of Medicine in St. Louis
LaYow Yu, Washington University School of Medicine in St. Louis
Shuyang Lin, Washington University School of Medicine in St. Louis
Jared S Fowles, Washington University School of Medicine in St. Louis
Daniel A C Fisher, Washington University School of Medicine in St. Louis
Sherwin Ng, Washington University School of Medicine in St. Louis
Wei Yang, Washington University School of Medicine in St. Louis
Fan He, Washington University School of Medicine in St. Louis
Jingxian Liu, Washington University School of Medicine in St. Louis
Alexander B Kim, Washington University School of Medicine in St. Louis
Maggie J Cox, Washington University School of Medicine in St. Louis
Mary C Fulbright, Washington University School of Medicine in St. Louis
Stacey L Rentschler, Washington University School of Medicine in St. Louis
Li Ding, Washington University School of Medicine in St. Louis
Grant A Challen, Washington University School of Medicine in St. Louis
Stephen T Oh, Washington University School of Medicine in St. Louis
et al.

Journal

Nature Communications

Publication Date

1-16-2025

Volume

16

Issue

1

First Page

492

Document Type

Open Access Publication

DOI

10.1038/s41467-024-55643-7

Rights and Permissions

Kong, T., Laranjeira, A.B.A., Letson, C.T. et al. RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia. Nat Commun 16, 492 (2025). https://doi.org/10.1038/s41467-024-55643-7 This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Recommended Citation

Kong, Tim; Laranjeira, Angelo B A; Letson, Christopher T; Yu, LaYow; Lin, Shuyang; Fowles, Jared S; Fisher, Daniel A C; Ng, Sherwin; Yang, Wei; He, Fan; Liu, Jingxian; Kim, Alexander B; Cox, Maggie J; Fulbright, Mary C; Rentschler, Stacey L; Ding, Li; Challen, Grant A; Oh, Stephen T; and et al., "RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia." Nature Communications. 16, 1. 492 (2025).
https://digitalcommons.wustl.edu/oa_4/4785

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.